Karyopharm Therapeutics Inc. (44) | Intellectual Property (2)
- License Agreement, dated as of December 17, 2021, between the Registrant and Berlin-Chemie AG (Menarini Group) (Filed With SEC on March 1, 2022)
- Amendment to License Agreement, dated May 1, 2020, by and between Antengene Therapeutics Limited and the Registrant (Filed With SEC on August 4, 2020)